Amplification and overexpression of the IGF2 regulator PLAG1 in hepatoblastoma
about
Wnt pathway is involved in pleomorphic adenomas induced by overexpression of PLAG1 in transgenic miceIdentification of gene expression changes associated with the initiation of diapause in the brain of the cotton bollworm, Helicoverpa armigera.Integrated data analysis reveals uterine leiomyoma subtypes with distinct driver pathways and biomarkers.Pleomorphic adenoma gene 1 mediates the role of karyopherin alpha 2 and has prognostic significance in hepatocellular carcinoma.MicroRNA-492 is processed from the keratin 19 gene and up-regulated in metastatic hepatoblastoma.miR-141 contributes to fetal growth restriction by regulating PLAG1 expressionGene expression profiling of microdissected pancreatic ductal carcinomas using high-density DNA microarraysCorrelated expression of HMGA2 and PLAG1 in thyroid tumors, uterine leiomyomas and experimental modelsA subset of cutaneous and soft tissue mixed tumors are genetically linked to their salivary gland counterpart.IGFBP3 impedes aggressive growth of pediatric liver cancer and is epigenetically silenced in vascular invasive and metastatic tumorsOverview of the molecular biology of hepatocellular neoplasms and hepatoblastomas of the mouse liver.Disseminated carcinoma ex pleomorphic adenoma in an adolescent confirmed by application of PLAG1 immunohistochemistry and FISH for PLAG1 rearrangementLoss of imprinting of IGF2 correlates with hypermethylation of the H19 differentially methylated region in hepatoblastomaGenetics and epigenetics of hepatoblastoma.Diagnostic utility of molecular and cytogenetic analysis in lipoblastoma: a study of two cases and review of the literature.Circulating high mobility group AT-hook 2 and pleomorphic adenoma gene 1 in blood of patients with oral squamous cell carcinoma.PLAGL2 regulates actin cytoskeletal architecture and cell migration.Retroviral insertional mutagenesis in telomerase-immortalized hepatocytes identifies RIPK4 as novel tumor suppressor in human hepatocarcinogenesis.Upregulated genes at 2q24 gains as candidate oncogenes in hepatoblastomas.Cell type and context-specific function of PLAG1 for IGF2 P3 promoter activity.Pleomorphic adenoma gene-like 2 regulates expression of the p53 family member, p73, and induces cell cycle block and apoptosis in human promonocytic U937 cells.Modulation of PLAGL2 transactivation by positive cofactor 2 (PC2), a component of the ARC/Mediator complex.PLAG1 alteration in carcinoma ex pleomorphic adenoma: immunohistochemical and fluorescence in situ hybridization studies of 22 casesPLAG1 immunohistochemistry is a sensitive marker for Pleomorphic Adenoma: a comparative study with PLAG1 genetic abnormalities.Genetic disruption of the oncogenic HMGA2-PLAG1-IGF2 pathway causes fetal growth restriction.PLAG1 expression in mesenchymal tumors: an immunohistochemical study with special emphasis on the pathogenetical distinction between soft tissue myoepithelioma and pleomorphic adenoma of the salivary gland.Exome sequencing of hepatoblastoma reveals novel mutations and cancer genes in the Wnt pathway and ubiquitin ligase complex.PLAG1 expression in cutaneous mixed tumors: an immunohistochemical and molecular genetic study.Pdx1- and Ngn3-Cre-Mediated PLAG1 Expression in the Pancreas Leads to Endocrine Hormone Imbalances That Affect Glucose Metabolism
P2860
Q28267847-7B1D0154-2119-464F-BE33-6B21860385A0Q30505168-44156303-2175-44BC-B3AC-0083A6889E00Q31038292-A9F3D77C-565A-4219-83F6-BE7069E84F66Q34007013-0E1B0414-1C75-4FEA-988F-B6DC6231F460Q34164408-31725E76-D778-4272-8B3C-EABC5F9EA455Q34648245-362B6E6B-639F-4A02-8E61-00BC76A2B8CBQ34928555-4727E9FF-1434-43AC-92C3-018A8C8CEABAQ35091563-42064AB2-30E1-4322-9BA1-C9D2C721EF9CQ35600864-C52D7A4C-F7A9-4F74-8B9A-19C339204F86Q35951090-C89E09F1-B749-42CF-8A9E-E47B3DCED200Q36086439-99F895F5-8846-4414-A05D-333BBA75BB20Q36174388-D1A84D65-653C-4609-BBE4-31C504F20AC6Q37010551-950D68F2-6C14-4164-8A71-80B893ED007CQ38027114-2D0D7528-1FC2-42B7-A432-B1AE902F9258Q38179091-BE569847-7B79-40CB-B0D3-AF0734B7316AQ38709288-F6ECBD69-5892-44C7-8BEB-A561D340A4CBQ39010968-12848949-5F7E-47DD-AD8B-C8BCADCF86BCQ39035358-9208A75F-DC6F-42FF-95E8-DB3B30CBCBC6Q39070947-5CF98010-9687-42A0-8011-5C39438BA1DCQ39268902-5B75E42C-E6F6-4336-A786-74DC0C1B960FQ39444603-893333B8-0AD3-4AD6-ADE2-A076C397ECAEQ39760686-282C4F5E-5FF7-48B9-90B8-988E44A2A08EQ41835934-C898BD53-8E60-40AA-8DF4-CB048DDF56B5Q42513500-AB040707-A6D8-4207-9907-265B49B3E40CQ48159382-BF908900-EBC1-418C-87F6-EEF93C4E9F66Q54332755-800865D7-D7AB-43CE-92D9-4E347351B7B6Q54346071-BBF77B93-46FB-47E6-8BEE-39E93F0DD1D0Q54348373-6BA79574-E049-41C2-B9E5-E5AA14350346Q56777707-A5BBC0FB-458D-4820-B73D-682E970CDD02
P2860
Amplification and overexpression of the IGF2 regulator PLAG1 in hepatoblastoma
description
2004 nî lūn-bûn
@nan
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Amplification and overexpression of the IGF2 regulator PLAG1 in hepatoblastoma
@ast
Amplification and overexpression of the IGF2 regulator PLAG1 in hepatoblastoma
@en
Amplification and overexpression of the IGF2 regulator PLAG1 in hepatoblastoma
@nl
type
label
Amplification and overexpression of the IGF2 regulator PLAG1 in hepatoblastoma
@ast
Amplification and overexpression of the IGF2 regulator PLAG1 in hepatoblastoma
@en
Amplification and overexpression of the IGF2 regulator PLAG1 in hepatoblastoma
@nl
prefLabel
Amplification and overexpression of the IGF2 regulator PLAG1 in hepatoblastoma
@ast
Amplification and overexpression of the IGF2 regulator PLAG1 in hepatoblastoma
@en
Amplification and overexpression of the IGF2 regulator PLAG1 in hepatoblastoma
@nl
P2093
P2860
P50
P356
P1476
Amplification and overexpression of the IGF2 regulator PLAG1 in hepatoblastoma
@en
P2093
Andrea Zatkova
Arend Koch
Barbara J Lamb
Christa Fonatsch
Dietrich von Schweinitz
Katharina Wimmer
Markus Eckart
Sam M Hanash
Torsten Pietsch
Wolfgang Hartmann
P2860
P304
P356
10.1002/GCC.10307
P407
P577
2004-02-01T00:00:00Z